News and features

Scientists have created a dynamic database driven by artificial intelligence which is collecting together the world’s research on coronavirus in a single online space.

The Institute of Cancer Research, London, has broadly welcomed the approval of targeted hormone therapies enzalutamide and abiraterone as first-line NHS treatments for men with advanced prostate cancer.

A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer. The protocol is being eagerly sought by hospitals to help reduce demands on the NHS during the COVID-19 pandemic.

A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.

As sports events around the world are put on hold in the midst of the coronavirus crisis, Joanne Duffy finds out how #teamICR have come together to support each other, adapt their training and focus on what really matters to them.

Staff and students from across The Institute of Cancer Research, London, are using their scientific and clinical expertise as part of the national response to the coronavirus pandemic.

Researchers have enhanced a new method for inhibiting the protein HSP72, known to be important in helping cancer cells survive and resist treatment, which will help scientists move closer to discovering a new cancer drug that targets the protein.

Brain cancer in infants is biologically distinct from other childhood brain tumours and could be successfully treated with targeted drugs, a new study has shown.

Nine world-leading medical imaging centres from across the UK will come together to form an integrated network for standardising and validating the use of cutting-edge imaging techniques in cancer treatment.

The Institute of Cancer Research, London, has now ceased most of its ‘wet lab’ research as part of a series of measures to safeguard staff and students from coronavirus – but we are proud to be supporting the national effort against the pandemic.

The Institute of Cancer Research, London, is putting in place a series of measures to safeguard its staff and students in response to the coronavirus pandemic, while also seeking to minimise the long-term impact upon our life-saving research.

The Institute of Cancer Research, London, is doing everything it can to safeguard its staff and students in response to the coronavirus pandemic while attempting to minimise the inevitable disruption to its life-saving research.